GlassScriptPhysician profile
Jill A Cunningham
NPI 1578587515
$1,287.03
in general payments reported to CMS, 2019-2025
14 companies · $72.59 in 2025
The $72.59 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $170 · 2022: $537 · 2023: $370 · 2024: $137 · 2025: $72.59.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $579.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $579.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $236.29 | 2021-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Supernus Pharmaceuticals, INC. | $219.97 | 2022-2023 | Qelbree |
| Corium, LLC | $216.68 | 2022-2024 | Azstarys |
| Ironshore Pharmaceuticals INC. | $197.55 | 2021-2024 | Jornay Pm |
| Glaxosmithkline, LLC. | $130.44 | 2021-2025 | Shingrix, Bexsero |
| Takeda Pharmaceuticals U.S.A., INC. | $87.24 | 2021-2022 | |
| Sanofi Pasteur INC. | $47.22 | 2021-2022 | |
| Ucb, INC. | $33.66 | 2023 | Nayzilam |
| Pfizer INC. | $32.50 | 2021-2024 | |
| Kaleo, INC. | $26.49 | 2021-2022 | |
| Seqirus USA INC | $18.16 | 2022 | |
| Qol Medical, LLC | $13.78 | 2023 | Sucraid |
| Ultragenyx Pharmaceutical INC. | $13.56 | 2022 | |
| Cumberland Pharmaceuticals, INC. | $13.49 | 2024 | Kristalose |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jill Cunningham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.